Your session is about to expire
← Back to Search
Study Summary
This trial is comparing two methods to reduce post-surgical pain related to a Cesarean section. One method is scar infiltration with Lidocaine and the other is scar deactivation with acupuncture.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I had a C-section with a vertical cut or it was an emergency.I completed a 12-week break after having Scar Deactivation for my cesarean section scar.I had a procedure to treat my cesarean section scar within the last 3 months.You have had a cesarean section with lidocaine injected into the scar.I have an infection around a scar.I am over 3 months postpartum and started having abdominal/back pain after a C-section.I have had surgery to correct a Cesarean section scar.I am a female over 18 and a beneficiary of the Department of Defense.
- Group 1: Scar Deactivation Surface Release
- Group 2: Scar Infiltration with 0.25-1% Lidocaine
- Group 3: Physical Therapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment into this experiment still available for participants?
"Yes, clinicaltrials.gov indicates that this medical experiment has opened its enrolment process. This research project was first posted in June 2019 and recently updated on April 5th 2022; it requires 60 participants from a single site."
How many applicants are eligible for this experiment?
"Affirmative. On clinicaltrials.gov, it is apparent that this experiment began on June 1st 2019 and has recently been updated on April 5th 2022. It appears to be actively seeking 60 individuals from a single research site for the trial."
Share this study with friends
Copy Link
Messenger